From Name:
From Email:
To Name:
To Email:

Optional Message:


RFA therapy shows promise in treating pancreatic cancer

from By Dr. Afsaneh Motamed-Khorasani

Pancreatic cancer has been ranked as the fourth-leading cause of cancer-related mortality in the West with 20 percent, 40 percent and 40 percent of the cases presented with a resectable lesion, unresectable locally advanced and metastatic disease, respectively. Pancreatic ductal adenocarcinoma (PDAC) has been reported to be one of the most aggressive types of pancreatic cancers, as well as having the highest occurrence among pancreatic cancers with poor chemoradiation results. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063